High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon. [electronic resource]
Producer: 20160105Description: 517-24 p. digitalISSN:- 1815-7920
- Adolescent
- Adult
- Aged
- Antitubercular Agents -- adverse effects
- Cameroon
- Clofazimine -- therapeutic use
- Cohort Studies
- Confidence Intervals
- Developing Countries
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Therapy, Combination
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Ethambutol -- therapeutic use
- Female
- Fluoroquinolones -- therapeutic use
- Gatifloxacin
- Humans
- Isoniazid -- therapeutic use
- Kanamycin -- therapeutic use
- Male
- Middle Aged
- Odds Ratio
- Prospective Studies
- Prothionamide -- therapeutic use
- Pyrazinamide -- therapeutic use
- Risk Assessment
- Time Factors
- Treatment Outcome
- Tuberculosis, Multidrug-Resistant -- diagnosis
- Young Adult
- Assessment of Medication Adherence
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.